UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 5
May-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1905S76


Registration ID:
230964

Page Number

1173-1183

Share This Article


Jetir RMS

Title

Analytical Methods For Estimation Of Sitagliptin For Bulk Tablet And Dosage Form

Abstract

Sitagliptin is a dipeptidyl-peptidase inhibitor (DPP-4 inhibitor) Synonyms of sitagliptn is sitagliptina that has recently been approved for the therapy of type 2 diabetes. Like other DPP-4 inhibitors its action is mediated by increasing levels of the incretin hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide. Sitagliptin is effective in lowering HbA1c, and fasting as well as postprandial glucose in monotherapy and in combination with other oral antidiabetic agents. It stimulates insulin secretion when hyperglycemia is present and inhibits glucagon secretion. Absorption of Sitagliptin is 87% orally bioavailable and taking it with or without food does not affect its pharmacokinetics4. Sitagliptin reaches maximum plasma concentration in 2 hours. Route of elimination Approximately 79% of sitagliptin is excreted in the urine as the unchanged parent compound. 87% of the dose is eliminated in the urine and 13% in the feces .A new simple and precise reverse phase high performance liquid chromatographic method has been developed and subsequently validated for the estimation of Sitagliptin phosphate monohydrate in bulk and its pharmaceutical dosage form. The assay of Sitagliptin was found to be 99.89 %. The results of the study showed that the proposed RP-HPLC method is simple, rapid, precise, reliable, accurate and economical which is useful for the routine determination of Sitagliptin phosphate in bulk and its pharmaceutical dosage form. This assessment encompasses various analytical methods such as spectrometry and spectrophotometric , ultra performance liquid chromatography (UPLC), high performance thin layer chromatography (HPTLC) and gas chromatography-mass spectrometry (GC-MS) for the estimation of sitagliptin in single and/or in combination.

Key Words

Sitagliptin Phosphate, Analytical methods, Type-2 d,iabetes, method validation

Cite This Article

"Analytical Methods For Estimation Of Sitagliptin For Bulk Tablet And Dosage Form", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 5, page no.1173-1183, May-2019, Available :http://www.jetir.org/papers/JETIR1905S76.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Analytical Methods For Estimation Of Sitagliptin For Bulk Tablet And Dosage Form", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 5, page no. pp1173-1183, May-2019, Available at : http://www.jetir.org/papers/JETIR1905S76.pdf

Publication Details

Published Paper ID: JETIR1905S76
Registration ID: 230964
Published In: Volume 6 | Issue 5 | Year May-2019
DOI (Digital Object Identifier):
Page No: 1173-1183
Country: -, -, - .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0003032

Print This Page

Current Call For Paper

Jetir RMS